+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Randomized Trial Comparing Cyclosporine Induction With Sequential Therapy in Renal Transplant Recipients



A Randomized Trial Comparing Cyclosporine Induction With Sequential Therapy in Renal Transplant Recipients



Journal of Urology 160(6): 2299-2300




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062672037

Download citation: RISBibTeXText

DOI: 10.1016/s0022-5347(01)62331-0


Related references

A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients. American Journal of Kidney Diseases 30(5): 639-645, 1997

A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients. Transplantation Proceedings 19(1 Pt 3): 1996-1997, 1987

Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant. Transplant International 18(4): 419-422, 2005

Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen. Journal of the American Society of Nephrology 13(2): 536-543, 2002

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 75(6): 844-851, 2003

A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients. Transplantation Proceedings 34(5): 1625-1626, 2002

A Randomized Trial Comparing Cyclosporine With Antilymphoblast-GlobulinAzathioprine For Renal Allograft Recipients. Transplantation 45(2): 380-385, 1988

Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. Transplantation Proceedings 33(1-2): 1034-1035, 2001

Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study. Transplantation Proceedings 23(1 Pt 2): 1041-1042, 1991

A prospective clinical trial comparing low dose OKT3 prophylaxis and prednisolone cyclosporine treatment in renal transplant recipients. Kidney International 43(4): 971-972, 1993

A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results. Transplantation 78(11): 1653-1660, 2004

Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. Clinical Transplantation 21(2): 192-201, 2007

A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Transplantation 45(2): 380-385, 1988

Long-Term Follow-Up Of A Randomized Trial Comparing T Cell Depletion With A Combination Of Methotrexate And Cyclosporine In Adult Leukemic Marrow Transplant Recipients. Transplantation 58(8): 887-891, 1994

Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. Transplantation Proceedings 26(3): 1829-1830, 1994